Mirum Pharmaceuticals, Inc. (MIRM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.97B |
| Enterprise Value | 3.99B |
| P/E Ratio | -6.21 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 9.21 |
| Price/Book Ratio | -114.41 |
| Enterprise/Revenue | 9.95 |
| Enterprise/EBITDA | -8.17 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1.35 |
| Operating Margin | -0.25 |
| Return On Assets | -0.88 |
| Return On Equity | -7.34 |
| Revenue | 521.31M |
| Revenue/Share | 10.24 |
| Gross Profit | 420.73M |
| EBITDA | 17.21M |
| Net Income | -23.36M |
| Diluted EPS | -0.47 |
| Total Cash | 373.69M |
| Total Cash/Share | 5.7 |
| Total Debt | 743.56M |
| Total Debt/Equity | -13.72 |
| Current Ratio | 2.07 |
| Book Value Per Share | -0.83 |
| 52-Week Change | 32.66 |
| 52-Week High | 130 |
| 52-Week Low | 63.23 |
| Moving Average 50 Days | 89.13 |
| Moving Average 200 Days | 98.51 |
| Average Volume | 692,196 |
| Shares Outstanding | 65.28M |
| % Held by Institutions | 122.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |